Who is sponsoring NCT05450055?

NCT05450055 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT05450055?

Interventions in NCT05450055: intraperitoneal lidocaine analgesic or normal saline as control.

What condition does NCT05450055 study?

NCT05450055 studies Ovarian Cancer, Post Operative Pain.

Is NCT05450055 still recruiting?

NCT05450055 is currently not yet recruiting. Last updated 13 July 2022.

Last reviewed 2022-07-13 · How we verify

NCT05450055

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Not yet recruiting NA Last updated 13 July 2022

What this trial tests

NA trial testing intraperitoneal lidocaine analgesic or normal saline as control in Ovarian Cancer in 60 participants. Not yet recruiting.

Timeline

18 July 2022

Primary endpoint
30 July 2024

30 July 2029

Quick facts

Lead sponsor	Peking University Third Hospital
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	18 July 2022
Primary completion	30 July 2024
Estimated completion	30 July 2029
Sites	1 location across China

Drugs / interventions tested

intraperitoneal lidocaine analgesic or normal saline as control

Conditions studied

Ovarian Cancer — all drugs for Ovarian Cancer →
Post Operative Pain — all drugs for Post Operative Pain →

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 75, female only, with Ovarian Cancer or Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this trial is to improve the postoperative analgesia effect and prognosis of patients with ovarian cancer after laparotomy surgery. This is a randomized, double-blind, controlled trial to evaluate analgesia and patient outcomes after local peritoneal anesthesia after surgery.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.
Pu T, Sun J, Ren G, Li H. · · 2025 · cited 34× · PMID 40456735 · DOI 10.1038/s41392-025-02241-8
The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities.
Zhang C, Guo X, Liu P, Wang Y, et al · · 2025 · cited 6× · PMID 41152924 · DOI 10.1186/s13045-025-01748-5
Anaesthetic Techniques and Strategies: Do They Influence Oncological Outcomes?
Murphy L, Shaker J, Buggy DJ. · · 2023 · cited 3× · PMID 37366886 · DOI 10.3390/curroncol30060403

Verify or expand the search:

Other recruiting trials for Ovarian Cancer

Currently open trials in the same condition.

NCT06412120 — Study Evaluating Safety, Tolerability, and Metabolism of Niraparib · Phase 4 · recruiting
NCT06930755 — Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer · Phase 1 · recruiting
NCT07318558 — A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) · Phase 3 · recruiting
NCT07491081 — EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection · NA · recruiting
NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05450055 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 13 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05450055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing